NHS Framework Agreement, Branded Medicines for London and South of England
NHS Framework Agreement, Branded Medicines for London and South of England and NHS Framework for the Midlands & East and North of England Regions – Bevacizumab.
Buyer
NHS England
Value
£1,110,294,056
Published
17 Sept 2021
Closes
4 Jun 2021
Procurement details
Source
Find a Tender
Region
United Kingdom
Procurement method
Open
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
Lots
Lot 1 CM/PHR/20/5598/01 - NHS Framework LONDON Branded Medicines - Tranche B.
Value not provided
CM/PHR/20/5598/01 - NHS Framework for LONDON Branded Medicines - Tranche B.Period of framework: 1 September 2021 to 31 August 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 Months
Delivery: United Kingdom, London
Lot 2 CM/PHR/20/5598/02 - NHS Framework LONDON Branded Medicines – Annual Tranche.
Value not provided
CM/PHR/20/5598/02 - NHS Framework for the LONDON Branded Medicines - Annual Tranche. Period of framework: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months
Delivery: United Kingdom, London
Lot 5 CM/PHR/20/5598/05 - NHS Framework SOUTH of England Annual Tranche.
Value not provided
CM/PHR/20/5598/05 - NHS Framework for the SOUTH of England Annual Tranche.Period of Framework: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months
Delivery: United Kingdom
Lot 3 CM/PHR/20/5598/03 - NHS Framework SOUTH of England Tranche A.
Value not provided
CM/PHR/20/5598/03 - NHS Framework for the SOUTH of England Tranche A.Period of Framework: 1 September 2021 to 31 August 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months
Delivery: United Kingdom
Lot 4 CM/PHR/20/5598/04- NHS Framework SOUTH of England - Tranche B.
Value not provided
CM/PHR/20/5598/04- NHS Framework for SOUTH of England - Tranche B.Period of framework: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months
Delivery: United Kingdom
Lot 6 CM/PHR/20/5598/06 - NHS Framework Midlands & East and NofE – Bevacizumab
Value not provided
CM/PHR/20/5598/06 - NHS Framework for the Midlands & East and North of England Regions – Bevacizumab
Delivery: United Kingdom
Documents
No document metadata is available for this public record.
Contains public sector information licensed under the Open Government Licence v3.0.